⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MNOV News
Medicinova, Inc.
ROTH to Host 5th Annual Healthcare Opportunities Conference on September 29 in New York City
globenewswire.com
ANVS
CRVO
MGNX
MNOV
MediciNova to Participate in Two Investor Conferences in September
globenewswire.com
MNOV
Form 8-K
sec.gov
MNOV
Form 8-K
sec.gov
MNOV
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
globenewswire.com
MNOV
MediciNova CEO Provides Shareholder Update
globenewswire.com
MNOV
Form 8-K
sec.gov
MNOV
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
globenewswire.com
MNOV
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
globenewswire.com
MNOV
MN-166 Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
MNOV